EEG
ASXC

E.E. Geduld’s Asensus Surgical, Inc. ASXC Stock Holding History

E.E. Geduld’s Portfolio ASXC Stock Details ASXC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-1,538
Closed -$85K – 185
2016
Q1 		$85K Buy
1,538
+769
+100% +$32.9K 0.12% 107
2015
Q4 		$25K Buy
+769
New +$24.8K 0.02% 155

Other funds holding ASXC

AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return
SHI
SV Health Investors Boston, Massachusetts $32.3M AUM 20.15% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
SG
StepStone Group La Jolla, California $207M AUM 12.33% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MCM
Masters Capital Management Atlanta, Georgia $3.03B AUM 57.21% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

E.E. Geduld's ASXC Position: Q2 2016 in Review

E.E. Geduld sold out of Asensus Surgical, Inc. (ASXC) in Q2 2016, closing a stake of 1,538 shares — an estimated $85K sold.

E.E. Geduld first reported a position in ASXC in Q4 2015 and held it in 2 quarters. The position peaked at $85K in Q1 2016. 84 funds tracked by Wall St. Rank hold ASXC as of Q2 2016.

  • E.E. Geduld reported no remaining Asensus Surgical, Inc. position as of Q2 2016 after selling out during the quarter.
  • E.E. Geduld sold 1,538 Asensus Surgical, Inc. shares in Q2 2016, an estimated $85K.
  • E.E. Geduld first reported a position in Asensus Surgical, Inc. in Q4 2015 and held it in 2 quarters.
  • E.E. Geduld's Asensus Surgical, Inc. position peaked at $85K in Q1 2016.
  • 84 funds tracked by Wall St. Rank held Asensus Surgical, Inc. as of Q2 2016.

Based on E.E. Geduld's 13F filing for Q2 2016, filed 8 Aug 2016.